期刊文献+

豪迈胱抑素C定量检测系统的性能验证

Performance Verification of the Quantitative Detection System in the Detection of HOMA Cystatin C
下载PDF
导出
摘要 目的:验证由豪迈胱抑素c检测试剂盒和贝克曼库尔特UniCelDxC800全自动生化分析仪组成的检测系统的性能特征。方法:对该检测系统的精密度、正确度、可报告范围和参考区问进行验证。结果:2个不同浓度水平样本的批内、批间变异系数均小于2%,均小于厂家声明;对厂家的定值参考物质进行检测,低浓度参考物质的绝对偏差为0.03~0.06mg/L,高浓度参考物质的回收率为94%~102%。使用厂家的定值物质进行回收试验,回收率为104.5%~108.4%。绝对偏差和回收率均与厂家声明一致;验证的分析测量范围为0.10~8.0mg/L,临床可报告范围为0.10~16.0mg/L;验证的参考区间与厂家声明的(0.57~1.01mg/L)一致。结论:由豪迈胱抑素C检测试剂盒和贝克曼库尔特UniCelDxC800全自动生化分析仪组成的检测系统的性能特征与豪迈公司声明一致,本研究所用性能验证的方案和方法简便、可行。 Objective: To verify the main performance characteristics of the detection system composed of HOMA cystatin C assay kit and Beckman-Coulter UniCel DxC800 Synchron Clinical System. Methods The precision, trueness, reportable range and reference interval of the quantitative detection system were analyzed according to the guidelines of CLSI. Results: For the two different levels samples, the coefficients of variation of intra-assay and inter-assay were less than 2%, less than manufacturers statement. The absolute deviations of the low concentration reference materials were 0.03-0.06mg/L, the recoveries of the high concentration reference materials were 94%-102%. The recovery tests were applied by using HOMA reference materials.The recoveries were 104.5%-108.4%. The absolute deviations and the recoveries were consistent with manufacturers statement. The verified measurement range was 0.10-8.0mg/L, the clinical reportable range was 0. 10-16.0mg/L. The verified reference intervals were 0.57-1.01mg/L, and consistent with with manufacturers statement. Conclusion: The main performance characteristics of the quantitative detection system in the detection of cystatin C were consistent with manufacturers statement.The performance verification procedures and methods were simple and practicable.
作者 林文涛 沙丹
出处 《中国医疗器械信息》 2013年第5期13-16,37,共5页 China Medical Device Information
关键词 胱抑素C 性能验证 定量测定 cystatin C, performance verification, quantitative detection system
  • 相关文献

参考文献6

  • 1U.S.Department of Health and Human Services,Centers for Medicare & Medicaid Services.Clinical laboratory improvement amendments of 1988: final rule [S]. Fed Register, 2003: 3704. 被引量:1
  • 2张葵.定量检测系统方法学性能验证实验的基本方法[J].临床检验杂志,2009,27(5):321-323. 被引量:76
  • 3王治国著..临床检验方法确认与性能验证[M].北京:人民卫生出版社,2009:453.
  • 4Clinical and Laboratory Standards Institute.User verification of performance for precision and trueness:approved guideline second edition[S].EP 15- A2(e),CLSI,2005. 被引量:1
  • 5杨有业,张秀明主编..临床检验方法学评价[M].北京:人民卫生出版社,2009:377.
  • 6CLSI.C28-A2.How to define and determine reference intervals in the clinical laboratory;Approved guideline-second edition,2000. 被引量:1

二级参考文献11

  • 1毕波,吕元.定量检测方法学性能验证的系统设计[J].中华检验医学杂志,2007,30(2):143-145. 被引量:153
  • 2U. S. Department of Health and Human Services, Centers for Medicare&Medicaid Services. Clinical laboratory improvement amendments of 1988 :final rule [ S]. Fed Register,2003:3704. 被引量:1
  • 3ISO 15189.医学实验室质量和能力认可准则[s].中国合格评定国家认可委员会,2008:1-36. 被引量:6
  • 4CLSI. EP5-A. Evaluation of precision performance of clinical chemistry devices [ S]. 1999 : 1-28. 被引量:1
  • 5CLSI. EP6-A2. Evaluation of the linearity of quantative analytical methods [ S ]. 2003 : 1-47. 被引量:1
  • 6CLSI. C28-A2. How to define and determine reference intervals in the clinical laboratory [ S ]. 2000 : 1-31. 被引量:1
  • 7CLSI. EP17-A. Protocols for determination of limits of detection and limits of quanitation [ S]. 2004 : 1-39. 被引量:1
  • 8CLSI. EP7-A2. Interference testing in clinical chemistry[ S]. 2005: 1-47. 被引量:1
  • 9Broughton P,Gowenlock A,McCormack J,et al. A revised scheme for the evaluation of automatic instruments for use in clinical chemistry [ J ]. Ann Clin Biochem,2007,11 ( 6 ) : 207-218. 被引量:1
  • 10CLSI. EP15-A. User demonstration of performance for precision and accuracy [ S]. 2001 : 1-15. 被引量:1

共引文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部